Medivation Effects a Stock Dividend on Its Common Stock
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 09/16/15 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it has effected a stock dividend on its common stock, in which each outstanding share of common stock received an additional share of common stock.
Medivation''s common stock will begin trading on a post-dividend basis on the NASDAQ Global Select Market at the opening of trading today, September 16, 2015.
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at
Rick Bierly
Chief Financial Officer
(415) 543-3470
Anne Bowdidge
Senior Director, Investor Relations
(650) 218-6900
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 16.09.2015 - 05:00 Uhr
Sprache: Deutsch
News-ID 1385747
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN FRANCISCO, CA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 137 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medivation Effects a Stock Dividend on Its Common Stock
"
steht unter der journalistisch-redaktionellen Verantwortung von
Medivation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
